article thumbnail

STAT+: Pharmalittle: Chinese drugmakers develop copycat weight loss drugs; SEC eyes supplier of research monkeys

STAT

… Chinese pharmaceutical companies are developing domestic versions of “miracle” weight-loss drugs as they take on Western drugmakers selling anti-obesity medication in one of the world’s biggest markets , The Financial Times tells us. Meanwhile, do keep us in mind if you hear anything interesting.

article thumbnail

Teva appoints Eric Hughes as head of R&D and Chief Medical Officer

European Pharmaceutical Review

Dr Eric Hughes joins Teva with experience in all phases of drug development at global pharmaceutical companies, most recently Boston-based Vertex Pharmaceuticals, which he joined last year. He will be based out of Teva’s US headquarters in Parsippany, New Jersey. . Dr Hughes earned his MD and PhD at Yale School of Medicine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Computational protocol provides cheaper route to manage cholesterol levels

Express Pharma

This approach developed in collaboration between an academic research laboratory and a pharmaceutical company is not just about lowering cholesterol—it’s about creating a new paradigm to design drugs that can prevent diseases by targeting proteins more cleverly.

article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

” Tony Cundell: Contract manufacturing organisations (CROs), start-up companies, established pharmaceutical companies and regulatory agencies are having difficulty recruiting and retaining technically-trained personnel. Dr Tony Cundell has a PhD in Microbiology from the Lincoln University, New Zealand.

Vaccines 128
article thumbnail

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Pharmaceutical Technology

We look forward to deepening our collaboration in next decades and contributing more to state-of-the-art clinical trials for efficient medicine to patients’ benefits throughout the world”, says XU Yi, CEO Teddy Clinical Research Laboratory. SZ) and Tigermed (300347.SZ SZ) and Tigermed (300347.SZ